Please assess the completion status of the following clinical trial:

Trial Title: Optimizing Propofol Dosing for (Preterm) Newborn Infants That Need Endotracheal Intubation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~All neonates admitted to the two participating intensive care units:~* Less than 28 days postnatal age~* Who need endotracheal intubation~Exclusion Criteria:~Patients with:~* Major congenital anomalies or neurological disorders,~* Neonates with an abnormal upper airway,~* Those receiving continuous sedatives or opioids, and~* Those whose mothers received sedatives or opioids before or during delivery will be excluded during the first 2 days of life.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 28 Days
- Healthy Volunteers: f

Study Arms:
- Propofol (Type: EXPERIMENTAL): A predetermined propofol dose is used in every 5 consecutive patients per age group. Starting dose is 1.0 mg/kg. Dose is increased or decreased with 0.5 mg/kg

Based on this trial design, predict the completion outcome and termination type (if applicable).